Publications
Specialty
Search
Pharmacy Learning Network
10/10/2024
Vials of Veklury (remdesivir) for injection are under a Class I recall after a customer found a glass particle in a vial.
IO Learning
10/10/2024
In this episode of the SIO Corner podcast, Muneeb Ahmed, MD, and Michael Soulen, MD, join AJ Gunn, MD, to talk about the origin of the Society of Interventional Oncology, where it fits in along the other radiology societies, and how the SIO Annual Meeting differs from those societies’ meetings.
Psych Congress Network, Neurology
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
Neurology
10/10/2024
Treatment outcome prediction models for patients with newly diagnosed epilepsy have a universally high risk of bias, researchers reported in a systematic review of nearly 50 such models published in the journal Epilepsia.
First Report Managed Care
10/10/2024
An American Urological Association/Society of Urologic Oncology guideline published in the Journal of Urology provides more than 3 dozen recommendations to guide clinicians through a current evidence-based approach to the diagnosis and management of nonmetastatic upper tract urothelial carcinoma (UTUC).
Oncology
10/10/2024
Momelotinib was well-tolerated, improved spleen and symptom responses, and reduced transfusion burden among a subgroup of patients with JAK inhibitor-naive myelofibrosis, determined an analysis of the phase 3 SIMPLIFY-1 study.
Oncology
10/10/2024
Nivolumab plus pomalidomide and dexamethasone plus or minus elotuzumab did not demonstrate a clinical benefit compared with pomalidomide and dexamethasone treatment for patients with relapsed/refractory multiple myeloma, according to phase 3 results from the Checkmate 602 trial.
Oncology
10/10/2024
While allogeneic stem cell transplantation is the preferred treatment for younger, transplant-eligible patients with relapsed/refractory peripheral T-cell lymphoma, it is currently not recommended as part of first-line consolidation, concluded long-term follow-up results from the AATT study.
EMSWorld
10/10/2024
US Ambulances for Ukraine have donated 77 surplus/used emergency vehicles to Ukraine so far, the bulk of them being fire engines and ambulances.
The Dermatologist
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
Psych Congress NP Institute
10/09/2024
Jonathan Meyer, MD, delves into the complexities of schizophrenia management and the future of treatment options.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/09/2024
The U.S. multicenter, single-blind, randomized controlled trial, "Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR," will enroll up to 532 subjects between 18 and 90 years of age with aortic valve stenosis who are undergoing TAVR.
Oncology
10/09/2024
According to results from the phase 3 KEYNOTE-522 trial, neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab significantly improved overall survival among patients with early-stage triple-negative breast cancer.
Psych Congress Network
10/09/2024
Bright light therapy (BLT) may be an effective adjunctive treatment for non-seasonal depressive disorders and improve response time for the initial treatment, according to results from a recent systematic review and meta-analysis published in JAMA Psychiatry.
EMSWorld
10/09/2024
The National Weather Service has issued a tornado watch for parts of Florida as Hurricane Milton approaches the state. The watch issued before 8:30 a.m. runs until 9 p.m. and for now includes all of the southern portion of the Florida peninsula up into Central Florida’s Polk and Osceola counties.
EP Lab Digest
10/09/2024
ZOLL Medical Press Release
EP Lab Digest
10/09/2024
Adagio Medical Press Release
EP Lab Digest
10/09/2024
Compass Surgical Partners, Bon Secours Mercy Health and AlignedCardio Press Release
EP Lab Digest
10/09/2024
Avive Solutions Press Release
EP Lab Digest
10/09/2024
Johnson & Johnson Press Release
NEW BRUNSWICK, N.J. -- Johnson & Johnson1 (NYSE: JNJ) announced today it has successfully completed the acquisition of V-Wave Ltd., a privately-held company focused on developing innovative treatment options for patients with heart failure. V-Wave will operate as part of Johnson & Johnson MedTech.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
